Folic acid and prevention of birth defects

Developmental Medicine and Child Neurology

Volumn 44, Issue 6, 2002, Pages 426-429

  Van Dyke, Don C ^a   Stumbo, Phyllis J ^b   Berg, Mary J ^c   Niebyl, Jennifer R ^b  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; HOMOCYSTEINE; METHOTREXATE; MULTIVITAMIN; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PYRIMETHAMINE; SULFAMETHOXAZOLE; TRIAMTERENE; TRIMETHOPRIM; TRIMETREXATE; VALPROIC ACID;

BIOCHEMISTRY; BIRTH DEFECT; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG METABOLISM; DRUG POTENTIATION; FOLIC ACID DEFICIENCY; HUMAN; INTESTINE ABSORPTION; NUTRITIONAL REQUIREMENT; PHARMACOGENETICS; PREGNANCY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK FACTOR;

ABNORMALITIES; ABSORPTION; ADULT; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; FEMALE; FOLIC ACID; HEMATINICS; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; NUTRITION PHYSIOLOGY; PRECONCEPTION CARE; PREGNANCY; RISK FACTORS;

EID: 0036075565     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162201002316     Document Type: Review

References (68)

1. The concentration of 'folic acid'
2. The concentration of 'folic acid'
3. Dietary sources of nutrients among US adults, 1989-1991
4. Folic acid and the prevention of neural tube defects
5. Food labeling: Health claims and label statements; Folate and neural tube defects
6. Folic acid and zinc supplements are required to meet maternal recommendations
7. Prevention of neural tube defects: Results of Medical Research Council vitamin study
8. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects
9. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
10. Knowledge and use of folic acid by women of childbearing age - United States, 1995 and 1998
11. Phenytoin - Folic acid: A review
12. Isolated congenital malabsorption of folic acid in a male infant: Insights into treatment and mechanisms of defects
13. Folate metabolism and neural tube defects: A review
14. Folate metabolism and requirements
15. DNA methylation and genetic instability in colorectal cancer cells
16. Frequent hypomethylation in Wilms tumors of pericentrometic DNA in chromosome 1 and 16
17. Methyl groups in carcinogenesis: Effects on DNA methylation and gene expression
18. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency
19. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats
20. Alternations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat
21. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats
22. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome
23. Possible basis for primary prevention of birth defects with folic acid
24. Homocystine metabolism in pregnancies complicated by neural tube defects
25. Pathophysiology, prevention, and potential treatments of neural tube defects
26. A candidate genetic risk for vascular disease: A common mutation in methylenetetrahydrofolate reductase
27. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
28. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations
29. Neural-tube defects and derangement of homocysteine metabolism
30. Maternal methionine supplementation promotes the remediation of axial defects in Axd mouse neural tube mutants
31. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos
32. Serum folate and risk of fatal coronary heart disease
33. Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid
34. Congenital heart defects and maternal derangement of homocysteine metabolism
35. Folic acid and reproduction
36. Does periconceptional multivitamin use reduce the risk of neural tube defects associated with other birth defects? Data from two population-based case-control studies
37. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate
38. Elevated rate of severe neural tube defects in a high-prevalence area in northern China
39. Prevention of neural tube defects with folic acid in China
40. Neural tube defects and periconceptional folic acid in England and Wales: Retrospective study
41. Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid
42. Folate status in women of childbearing age - United States, 1999
43. Failure of prescription prenatal vitamin products to meet United States Pharmacopia standards for folic acid dissolution
44. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally
45. Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use
46. The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother
47. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects
48. The Pregnancy Risk Assessment Monitoring System (PRAMS) Working Group: Pregnancy planning and pre-conceptional counseling
49. Reduction of plasma homocystine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
50. Fortification of foods with folic acid: How much is enough?
51. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
52. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA)
53. Pediatric news briefs - Folate levels rise
54. Eat right and take a multivitamin
55. Prevention of neural-tube defects
56. Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid - Pharmacology, therapeutic recommendations, and economics
57. Pharmacogenetic screening for susceptibility to fetal malformations in women
58. Folic acid antagonists during pregnancy and the risk of birth defects
59. Biological and clinical implications of the MTHFR C677T polymorphism
60. Inherited disorders of cobalamin transport and metabolism
61. Inherited disorders of folate transport and metabolism
62. Genetic contributions to environmentally-induced neural tube defects. Development: Advances on many fronts
63. Folate pathway gene alterations in patients with neural tube defects
64. Analysis of three folate pathway genes in a Midwestern neural tube defects population
65. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR
66. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
67. Decreased methylenetetrahydrofolate reductase activity due to the 677C-T mutation in families with spina bifida offspring
68. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects?